Variants in two gene members of the TNF ligand superfamily and Hepatitis C virus chronic disease
Gastroenterology and Hepatology from Bed to Bench,
Vol. 11 No. Supplement 1 (2018),
11 Azar 2018
,
Page s66-s72
https://doi.org/10.22037/ghfbb.v0i0.1535
Abstract
Aim: To assess the possible correlation between single nucleotide polymorphisms (SNPs) of two members of TNF ligand superfamily genes, tumor necrosis factor-? (TNF-?) and lymphotoxin-? (LTA), and HCV chronic disease.
Background: The causes of disease progression from hepatitis C virus (HCV) infection to chronic liver disease still remains unclear. Abnormal production of the cytokines alleged to be contributed to progression of the disease or viral persistence. Regulatory mechanisms that control the production of cytokines including genetic polymorphisms, especially at coding/regulatory regions of genes, may affect expression and secretion of the cytokines.
Methods: In this case-control investigation, 258 individuals with serologically proven chronic HCV infection and 277 healthy controls were studied. Genotyping of rs1799964 variant of TNF-? and rs909253 intronic variant in LTA gene were performed. To confirm the results of genotyping, 10% of the specimens analyzed again by sequencing approach.
Results: In this investigation, a significant association was observed between the TNF-? TC genotype and chronic HCV infection (P = 0.035). Moreover, the frequency of C allele was significantly different between control subjects in comparison with chronic HCV patients (P=0.02). On the other hand, no association was found between LTA gene polymorphism and susceptibility to chronic HCV infection.
Conclusion: These findings indicate that genetic variants like single nucleotide polymorphism in TNF-? rs1799964, could be a host factor associated with susceptibility to HCV chronic infection. However, further large scale investigations are needed to confirm this finding.
Keywords: Hepatitis C, Cytokine, Single nucleotide polymorphism, Lymphotoxin-?.
(Please cite as: Baradaran Ghavami SH, Mohebbi SR, Karimi KH, Azimzadeh P, Sharifian A, Mojahed Yazdi H, et al. Variants in two gene members of the TNF ligand superfamily and hepatitis C virus chronic disease. Gastroenterol Hepatol Bed Bench 2018;11(Suppl. 1):S66-S72).
- Hepatitis C
- Cytokine
- Single Nucleotide Polymorphism
- Lymphotoxin-?
How to Cite
References
Paladino N, Fainboim H, Theiler G, Schroder T, Munoz AE, Flores AC, et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. JVI 2006;80:9144-50.
Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. WJG 2007;13:5481-5.
Suruki RY, Mueller N, Hayashi K, Harn D, DeGruttola V, Raker CA, et al. Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev 2006;15:2521-5.
Karbalaei R, Piran M, Rezaei-Tavirani M, Asadzadeh-Aghdaei H, Heidari MH. A systems biology analysis protein-protein interaction of NASH and IBD based on comprehensive gene information. Gastroenterol Hepatol Bed Bench. 2017;10:194-201.
Sariban E, Imamura K, Luebbers R, Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. The J Cli Invest 1988;81:1506-10.
Zekri AR, Hafez MM, Bahnassy AA, Hassan ZK, Mansour T, Kamal MM, et al. Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study. BMC Res Notes 2008;1:106.
Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959-62.
Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000;43:1366-70.
Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N, Nogami C, et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 1996;16:390-9.
Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, et al. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 1997;42:2487-94.
Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, et al. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis 2006;193:98-101.
Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 2006;34:24-31.
Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, et al. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol 2002;97:714-20.
Tajbakhsh M, García Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M, et al. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother. 2012;67:1128-33.
Vidigal PG, Germer JJ, Zein NN. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol 2002;36:271-7.
Pestechian N, Rasekh H, Rostami-Nejad M, Yousofi HA, Hosseini-Safa A. Molecular identification of Giardia lamblia; is there any correlation between diarrhea and genotyping in Iranian population? Gastroenterol Hepatol Bed Bench. 2014;7:168-72.
Taremi M, Soltan Dallal M, Gachkar L, MoezArdalan S, Zolfagharian K, Reza Zali M. Prevalence and antimicrobial resistance of Campylobacter isolated from retail raw chicken and beef meat, Tehran, Iran. Int J Food Microbiol. 2006;108:401-403.
Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, et al. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Trans Res 2007;150:116-21.
Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, et al. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 2007;9:987-92.
Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, et al. TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis. J Hepatol 2005;43:944-50.
Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S, et al. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients. Tissue Antigens 2011;77:126-30.
Puthothu B, Bierbaum S, Kopp MV, Forster J, Heinze J, Weckmann M, et al. Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol 2009;20:157-63.
Basu M, Das T, Ghosh A, Majumder S, Maji AK, Kanjilal SD, et al. Gene-gene interaction and functional impact of polymorphisms on innate immune genes in controlling Plasmodium falciparum blood infection level. Plos One 2012;7:e46441.
Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991;173:209-19.
Elsammak MY, Al-Sharkaweey RM, Ragab MS, Amin GM, Kandil MH. In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection. Ann Trop Med Parasitol 2008;102:709-16.
Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol 2004;72:60-5.
Salehi Moghadam F, Mohebbi SR, Hosseini SM, Damavand B, Zali MR. A new subtype of hepatitis C virus genotype 3: analysis of available evidence. Hepat Mon 2013;13:e13380.
Grunhage F, Nattermann J. Viral hepatitis: human genes that limit infection. Best Pract Res Clin gastroenterol 2010;24:709-23.
Azimzadeh P RS, Mohebbi SR, Mahmoudi T, Vahedi M, Fatemi SR, Zali N, Zali MR. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genet 2012;205:501-7.
Behelgardi A HS, Mohebbi SR, Azimzadeh P, Derakhshani S, Karimi K. A Study on Genetic Association of Interleukin-16 Single Nucleotide Polymorphism (rs1131445) With Chronic Hepatitis B Virus Infection in Iranian Patients. Jundishapur J Microbiol 2015;8:e23411.
Azimzadeh P RS, Mirtalebi H, Reza Fatemi S, Kazemian S, Khanyaghma M. Association of co-stimulatory human B-lymphocyte antigen B7-2 (CD86) gene polymorphism with colorectal cancer risk. Gastroenterol Hepatol Bed Bench 2013;6:68-91.
Najjar Sadeghi R SN, Vahedi M, Mohebbi SR, zali MR. Association of intron and exon polymorphisms of p53 gene in Iranian patients with gastritis. Gastroenterol Hepatol Bed Bench 2013;6 Suppl 1:S45-51.
Karkhane M MS, Azimzadeh P, Avarandeh H, Kazemian S, Sharifian A, Hatami B. Genetic association between a single nucleotide polymorphism in Interleukin-16 (rs4072111) and susceptibility to chronic HCV infection in an Iranian population. Gastroenterol Hepatol Bed Bench 2018;11:42-7.
Chen Y, Pei J. An assessment of a TNF polymorphic marker for the risk of HCV infection: meta-analysis and a new clinical study design. Infect Genet Evol 2009;9:1356-63.
Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali MR, Sanaei M, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis. 2009;200:S244-47.
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun 2004;5:315-29.
Fletcher GJ, Samuel P, Christdas J, Gnanamony M, Ismail AM, Anantharam R, et al. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 2011;12:552-8.
Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, et al. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Gen 2007;121:483-90.
Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol 1992;10:411-52.
Garcia-Gonzalez MA, Nicolas-Perez D, Lanas A, Bujanda L, Carrera P, Benito R, et al. Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma. Plos One 2012;7:e46179.
Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, et al. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 2009;52:170-9.
BaradaranGhavami SH NS, Naghoosi H, Tahaei SME, Azimzadeh P, Damavand B, Romani S. Association between Lymphotoxin (LT-A) Gene Polymorphism and Susceptibility to Chronic Hepatitis C Infection in Iranian Patients. JKMU 2013;20:252-62.
BaradaranGhavami SH MS, Naghoosi H, Azimzadeh P, Tahaei E, Romani S, Almasi SH. Association of Tumor Necrosis Factor Alpha (TNF-α)-1031 Polymorphism with Chronic Infection of Patients with HCV. JBUMS 2012;14:70-6.
- Abstract Viewed: 147 times
- PDF Downloaded: 87 times